Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort StudyOriol Manuel, Atul Humar, Dinesh Kumar et al.|Clinical Infectious Diseases|2012Cited by 299
Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections ForumPer Ljungman, Dana G. Wolf, Oriol Manuel et al.|Clinical Infectious Diseases|2024Cited by 145
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort StudyJonathan Tschopp, Christian van Delden, Arnaud G. L’Huillier et al.|American Journal of Transplantation|2020Cited by 134
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective studyJean Regina, Loïc Lhopitallier, Matthaios Papadimitriou‐Olivgeris et al.|PLoS ONE|2020Cited by 64
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected PatientsStéphanie Bibert, Nicolas Guex, João Lourenço et al.|Frontiers in Immunology|2021Cited by 45